INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03696 INSILICO

Closed 08-13 16:08:14

46.380

+0.380

+0.83%

High49.000	Low45.220	Vol14.07M
Open46.740	D1 Closing46.000	Amplitude8.22%
Mkt Cap26.99B	Tradable Cap26.99B	Total Shares582.00M
T/O663.11M	T/O Rate2.42%	Tradable Shares582.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":46.38,"timestamp":1786608494007,"preClose":46,"halted":0,"volume":14065119,"delay":0,"changeRate":0.008260869565217446,"floatShares":582000000,"shares":582000000,"eps":-4.48,"marketStatus":"Closed","change":0.38,"latestTime":"08-13 16:08:14","open":46.74,"high":49,"low":45.22,"amount":663114386,"amplitude":0.082174,"askPrice":46.4,"askSize":500,"bidPrice":46.38,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-4.707,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786671000000},"marketStatusCode":5,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":46,"openAndCloseTimeList":[[1786584600000,1786593600000],[1786597200000,1786608000000]],"volumeRatio":0.852132,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03696","defaultTab":"news","newsList":[{"id":"1190966125","title":"Movement Alert｜INSILICO Rises 5.09% in Regular Trading, Announces Research Collaboration with Korean THPharm","url":"https://stock-news.laohu8.com/highlight/detail?id=1190966125","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190966125?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:01","pubTimestamp":1786597274,"startTime":"0","endTime":"0","summary":"On August 13, INSILICO rose 5.09% in regular trading, trading at 48.32 HKD/share, with turnover of HKD 318 million. The rally was driven by the announcement of a new research collaboration with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195640635","title":"Hong Kong Stock Movements: INSILICO (03696) Rises Over 4% Intraday, Announces Research Collaboration with South Korea's THPharm","url":"https://stock-news.laohu8.com/highlight/detail?id=1195640635","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195640635?lang=en_us&edition=fundamental","pubTime":"2026-08-13 11:28","pubTimestamp":1786591707,"startTime":"0","endTime":"0","summary":"Shares of INSILICO (03696) climbed more than 4% during trading before settling at a 3% gain to 47.38 Hong Kong dollars, with a turnover of 259 million Hong Kong dollars.In a recent announcement from...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1141","KCAI","VXUS","BK4585","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658977952","title":"Insilico Medicine Nominates Oral Lp(a) Inhibitor Ism0900 as Preclinical Candidate for Cardiovascular Risk Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2658977952","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658977952?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:34","pubTimestamp":1786538053,"startTime":"0","endTime":"0","summary":"Insilico Medicine nominates oral Lp(a) inhibitor ISM0900 as preclinical candidate for cardiovascular risk managementInsilico Medicine nominated ISM0900 as a preclinical candidate for cardiovascular ri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL5gmDHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100244765","title":"InSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1100244765","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100244765?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:46","pubTimestamp":1786441561,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999837","title":"Insilico Medicine Updates Financial Calendar with Interim Earnings Conference Calls","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999837","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658999837?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:45","pubTimestamp":1786441537,"startTime":"0","endTime":"0","summary":"Insilico Medicine updates financial calendar with interim earnings conference callsInsilico Medicine Cayman Topco scheduled an interim earnings conference call on Aug. 26, 2026 to discuss six-month re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL5dlVb6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153908417","title":"GTHT Initiates Coverage on INSILICO with \"Accumulate\" Rating, Setting a Price Target of HKD 73.23","url":"https://stock-news.laohu8.com/highlight/detail?id=1153908417","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153908417?lang=en_us&edition=fundamental","pubTime":"2026-08-10 10:20","pubTimestamp":1786328419,"startTime":"0","endTime":"0","summary":"GTHT has released a research report forecasting that INSILICO (03696) will achieve revenues of $189.47 million, $246.05 million, and $326.04 million for the years 2026, 2027, and 2028, respectively,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","02611","161027","EWH","03696","BK1564","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115695419","title":"Movement Alert｜INSILICO Rises 9.6% in Regular Trading, NLRP3 Inhibitor Receives Clinical Approval Plus JPMorgan Initiates Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=1115695419","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115695419?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:31","pubTimestamp":1786325484,"startTime":"0","endTime":"0","summary":"On August 10, INSILICO rose 9.6% in regular trading, trading at 50.9 HKD/share, with turnover of 92.32 million HKD. The rally was driven by dual catalysts: the NMPA clinical trial approval of its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"INSILICO Rises as NLRP3 Inhibitor Receives Clinical Approval Plus JPMorgan Initiates Coverage","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136673857","title":"Hong Kong Stocks Update | INSILICO Surges Over 9% as ISM8969/HT-001 Receives NMPA Clinical Trial Approval for Parkinson's Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1136673857","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136673857?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:10","pubTimestamp":1786083017,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) surged more than 9%, trading up 8.1% at HK$44.3 as of the latest update, with a turnover of HK$541 million.According to recent news from Insilico's official WeChat account,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","MDTX","PSYK","01611","HT","BK1612","BK1167","IBRN","BK1141","IBBJ","VXUS","BK4181","BK4588","IBBQ","BMED","03696","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115138879","title":"Movement Alert｜INSILICO Rises 5.61% in Regular Trading, Life Sciences Sector Rally and Positive Pipeline Catalysts Boost Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1115138879","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115138879?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:04","pubTimestamp":1786079065,"startTime":"0","endTime":"0","summary":"On August 7, INSILICO rose 5.61% in regular trading, trading at HK$43.5/share, with turnover of HK$325 million.The move was driven by a broad rally across the Life Sciences Tools and Services sector,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134662320","title":"INSILICO Adds 6.60 Million Shares in July, Bringing Issued Share Count to 582.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1134662320","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134662320?lang=en_us&edition=fundamental","pubTime":"2026-08-06 17:26","pubTimestamp":1786008391,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) filed its Monthly Return for the period ended 31 July 2026, detailing changes in share capital and equity incentives. Key figures   • Authorised share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657577222","title":"Insilico Medicine Nominates Ism9077 as Preclinical Candidate for Ocular Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2657577222","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657577222?lang=en_us&edition=fundamental","pubTime":"2026-08-06 08:30","pubTimestamp":1785976220,"startTime":"0","endTime":"0","summary":"Insilico Medicine nominates ISM9077 as preclinical candidate for ocular diseasesInsilico Medicine Cayman Topco nominated ISM9077, a potential first-in-class Target Y inhibitor, as a preclinical candid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3NbpZl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558253","title":"InSilico Medicine (SEHK:3696) Lands FDA Fast Track And Launches AI Drug Benchmarks","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558253","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558253?lang=en_us&edition=fundamental","pubTime":"2026-08-04 11:28","pubTimestamp":1785814137,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (SEHK:3696) received FDA Fast Track Designation for ISM6331, an AI-generated pan-TEAD inhibitor for malignant pleural mesothelioma.\nThe company secured NMPA IND approval for ISM8969/HT-001, a BBB-penetrant NLRP3 inhibitor for neuroinflammatory diseases such as Parkinson's, enabling parallel trials in China and Australia.\nInSilico Medicine Cayman TopCo launched a Drug Discovery and Development Benchmarks as a Service platform to measure AI and foundation model...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-sehk3696-lands-fda-fast-track-and-launches","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-sehk3696-lands-fda-fast-track-and-launches","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARTY","BK4585","03696","AIPO","LABU","QTOC","VTHR","BK1141","CHAT","AGIX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120232971","title":"Movement Alert｜INSILICO Falls 5.78% in Regular Trading, Sector-Wide Weakness Overshadows New IND Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1120232971","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120232971?lang=en_us&edition=fundamental","pubTime":"2026-08-03 13:26","pubTimestamp":1785734806,"startTime":"0","endTime":"0","summary":"On August 3, INSILICO fell 5.78% in regular trading, trading at 43.06 HKD/share, with turnover of approximately 517 million HKD. The decline came despite the company announcing on the same day that...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192196095","title":"Insilico Medicine Receives NMPA Approval for Clinical Trial of NLRP3 Inhibitor ISM8969/HT-001 for Parkinson's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=1192196095","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192196095?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:28","pubTimestamp":1785716913,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696.HK) has announced that its novel oral NLRP3 inhibitor, ISM8969/HT-001, co-developed with Shenzhen 衡泰生物科技有限公司 (Hengtai Biotech), has received clinical trial approval from...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1167","BK1612","IBBJ","BMED","BK1141","BK4181","BK4218","01611","PSYK","MDTX","03696","HT","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656709346","title":"Insilico Medicine Wins China NMPA IND Approval for Parkinson’s Drug Ism8969/ht-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2656709346","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656709346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:15","pubTimestamp":1785716149,"startTime":"0","endTime":"0","summary":"Insilico Medicine wins China NMPA IND approval for Parkinson’s drug ISM8969/HT-001Insilico Medicine received China NMPA IND clearance for ISM8969/HT-001, an oral blood-brain-barrier-penetrant NLRP3 in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL1kmsFJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656467703","title":"Insilico Medicine Cayman Topco - Receives Nmpa Ind Approval for ISM8969/Ht-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2656467703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656467703?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:15","pubTimestamp":1785716139,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN43Y06F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145899210","title":"Movement Alert｜INSILICO Rises 5.09% in Regular Trading, ISM6331 Granted FDA Fast Track Designation Plus Sector Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1145899210","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145899210?lang=en_us&edition=fundamental","pubTime":"2026-07-31 09:33","pubTimestamp":1785461603,"startTime":"0","endTime":"0","summary":"On July 31, INSILICO rose 5.09% in regular trading, trading at 44.52 HKD/share, with turnover of 43.21 million HKD. The stock rebounded after a cumulative decline of approximately 9% over the prior...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"INSILICO Rises; ISM6331 Granted FDA Fast Track Designation Plus Sector Recovery","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159094499","title":"Movement Alert｜INSILICO Falls 5.52% in Regular Trading, Trading at HK$40.94","url":"https://stock-news.laohu8.com/highlight/detail?id=1159094499","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159094499?lang=en_us&edition=fundamental","pubTime":"2026-07-30 11:23","pubTimestamp":1785381801,"startTime":"0","endTime":"0","summary":"On July 30, INSILICO fell 5.52% in regular trading, trading at HK$40.94/share, with turnover of HK$218 million.Within the Life Sciences Tools & Services sector where INSILICO belongs, the overall...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655898806","title":"Insilico Medicine Receives FDA Fast Track Designation for Ism6331, the Ai-Driven Pan-Tead Inhibitor, in Advanced Mesothelioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2655898806","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655898806?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:31","pubTimestamp":1785328314,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Receives FDA Fast Track Designation For Ism6331, The Ai-Driven Pan-Tead Inhibitor, In Advanced MesotheliomaJuly 29 (Reuters)-Insilico Medicine Cayman TopCo3696.HK:INSILICO MEDI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA213NP5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655518988","title":"Insilico Medicine's Pleural Mesothelioma Drug Receives US FDA Fast Track Designation; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655518988","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655518988?lang=en_us&edition=fundamental","pubTime":"2026-07-29 14:16","pubTimestamp":1785305797,"startTime":"0","endTime":"0","summary":"Insilico Medicine (HKG:3696) said ISM6331 received fast-track designation from the U.S. Food and Drug Administration for the treatment of adult patients with unresectable malignant pleural mesotheliom","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","03696","LABU","BK4588","BK1141"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://insilico.com","stockEarnings":[{"period":"1week","weight":0.1063},{"period":"1month","weight":0.0236},{"period":"3month","weight":-0.2103},{"period":"6month","weight":-0.3741},{"period":"1year","weight":0.9127},{"period":"ytd","weight":0.2386}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0507},{"period":"3month","weight":-0.036},{"period":"6month","weight":-0.0424},{"period":"1year","weight":0.0188},{"period":"ytd","weight":-0.0074}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InSilico Medicine Cayman TopCo is a company principally engaged in the artificial intelligence (AI)-driven drug discovery and pipeline development business. The Company mainly self-develops drug candidates, co-develops and partially retains certain intellectual property (IP) rights for out-licensed drugs as well as collaborates with other pharmaceutical companies without retaining any IP rights. The Company generated several clinical or IND-enabling stage assets using its own AI platform under the name of Pharma.AI. The Company is also engaged in software solutions and other discovery business related to non-pharma sectors.","exchange":"SEHK","name":"INSILICO","nameEN":"INSILICO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INSILICO(03696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INSILICO,03696,INSILICO股票,INSILICO股票老虎,INSILICO股票老虎国际,INSILICO行情,INSILICO股票行情,INSILICO股价,INSILICO股市,INSILICO股票价格,INSILICO股票交易,INSILICO股票购买,INSILICO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INSILICO(03696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}